BioAtla
Why Robinhood?
You can watch BioAtla and buy or sell other stocks, ETFs, and their options commission-free!About BCAB
BioAtla, Inc. engages in the development of novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its CAB portfolio include MABs & ADCS, BA3011, and BA3021.
BCAB Key Statistics
Stock Snapshot
As of today, BioAtla(BCAB) shares are valued at $1.75. The company's market cap stands at 145.43M, with a P/E ratio of -6.42.
As of 2026-10-26, BioAtla(BCAB) stock has fluctuated between $1.71 and $1.80. The current price stands at $1.75, placing the stock +2.3% above today's low and -2.8% off the high.
The BioAtla(BCAB)'s current trading volume is 551, compared to an average daily volume of 1.27M.
In the last year, BioAtla(BCAB) shares hit a 52-week high of $71.50 and a 52-week low of $1.71.
In the last year, BioAtla(BCAB) shares hit a 52-week high of $71.50 and a 52-week low of $1.71.
BCAB News
BioAtla ( (BCAB) ) has shared an announcement. On October 15, 2026, BioAtla entered into a new Standby Equity Purchase Agreement with Yorkville, giving the com...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.